Net gamma exposure for EyePoint Inc (EYPT) options was positive at the Nov 11, 2026 close, about $9.1K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for EYPT, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for EYPT, 2026-11-20(m), calls & puts
| Net GEX ($ per 1% move) | $0 |
|---|---|
| Call GEX ($ per 1% move) | $0 |
| Put GEX ($ per 1% move) | $0 |
| Call Wall | |
| Put Wall | |
| Gamma Flip (Zero Gamma) |
Net Gamma Exposure by Expiration
Showing results for EYPT, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|---|---|---|---|---|---|
| Nov 20, 2026 8 DTE monthly | $0 | $0 | $0 |
EYPT Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is EYPT gamma exposure positive or negative?
EyePoint net gamma exposure was positive on Nov 11, 2026, at $9.1K. It has been positive on 20 of the last 20 trading days.
How has EYPT gamma exposure changed recently?
EyePoint net gamma exposure went from $18.55K on Oct 14, 2026 to $9.1K on Nov 11, 2026. See the EYPT gamma exposure history for a longer view.
What is EyePoint Inc?
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care.